SCAIR® Case Study

A biopharma supplier undertakes a supply chain risk analysis to demonstrate its rigorous approach to client fulfilment

The Requirement

A supplier to major biopharmaceutical companies was identified as the sole source of certain biopharma materials. Consequently, one of these companies required evidence of the supplier’s supply chain risk analysis, as part of a due diligence exercise.

Furthermore, the supplier was coming under pressure internally from the finance team to reduce working capital in the form of safety stock. However, the supply chain leads were concerned about the message this would send about the resilience of their supply chains to customers.

The Solution

The Results

Friendly Assistant

Strengthen Your Supply Chains with SCAIR®

Talk to a supply chain risk expert now
Copyright © 2026 Intersys Ltd. All rights reserved.
arrow-uparrow-right linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram